F3 peptide-functionalized PEG-PLA nanoparticles co-administrated with tLyp-1 peptide for anti-glioma drug delivery
Quanyin Hu(University of Wisconsin–Madison), Jun Chen(Abbott Fund), Ting Kang(Fudan University), Mengyin Jiang(Shandong University of Traditional Chinese Medicine), Yifan Tu(Fudan University), Huimin Xia(Nanjing Drum Tower Hospital), Guangzhi Gu(Fudan University), Deyu Miao(Shandong University of Traditional Chinese Medicine), Lei Yao(Shanghai Jiao Tong University), Xiaoling Gao(Shanxi Medical University), Qingxiang Song(Shanghai Jiao Tong University), Zhiqing Pang(Fudan University), Zhongyang Liu(Beijing Proteome Research Center), Xinguo Jiang(Unknown), Hongzhan Chen(Shanghai Jiao Tong University)
Cited by 189
Related Papers
Correction: Corrigendum: Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalization
|Scientific Reports|2014|1.1k
Aptamer-functionalized PEG–PLGA nanoparticles for enhanced anti-glioma drug delivery
|Biomaterials|2011|569
The targeted delivery of anticancer drugs to brain glioma by PEGylated oxidized multi-walled carbon nanotubes modified with angiopep-2
|Biomaterials|2012|405
Targeting mesoporous silica-encapsulated gold nanorods for chemo-photothermal therapy with near-infrared radiation
|Biomaterials|2013|354
Lactoferrin-conjugated PEG–PLA nanoparticles with improved brain delivery: In vitro and in vivo evaluations
|Journal of Controlled Release|2008|349